###begin article-title 0
Macrophage Migration Inhibitory Factor Activates Hypoxia-Inducible Factor in a p53-Dependent Manner
###end article-title 0
###begin p 1
Conceived and designed the experiments: GS KH SO TA KF. Performed the experiments: SO TO KN ST TW TT. Analyzed the data: KH SO. Wrote the paper: GS KH SO.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Macrophage migration inhibitory factor (MIF) is not only a cytokine which has a critical role in several inflammatory conditions but also has endocrine and enzymatic functions. MIF is identified as an intracellular signaling molecule and is implicated in the process of tumor progression, and also strongly enhances neovascularization. Overexpression of MIF has been observed in tumors from various organs. MIF is one of the genes induced by hypoxia in an hypoxia-inducible factor 1 (HIF-1)-dependent manner.
###end p 3
###begin title 4
Methods/Principal Findings
###end title 4
###begin p 5
###xml 56 61 <span type="species:ncbi:9606">human</span>
The effect of MIF on HIF-1 activity was investigated in human breast cancer MCF-7 and MDA-MB-231 cells, and osteosarcoma Saos-2 cells. We demonstrate that intracellular overexpression or extracellular administration of MIF enhances activation of HIF-1 under hypoxic conditions in MCF-7 cells. Mutagenesis analysis of MIF and knockdown of 53 demonstrates that the activation is not dependent on redox activity of MIF but on wild-type p53. We also indicate that the MIF receptor CD74 is involved in HIF-1 activation by MIF at least when MIF is administrated extracellularly.
###end p 5
###begin title 6
Conclusion/Significance
###end title 6
###begin p 7
MIF regulates HIF-1 activity in a p53-dependent manner. In addition to MIF's potent effects on the immune system, MIF is linked to fundamental processes conferring cell proliferation, cell survival, angiogenesis, and tumor invasiveness. This functional interdependence between MIF and HIF-1alpha protein stabilization and transactivation activity provide a molecular mechanism for promotion of tumorigenesis by MIF.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 216 219 216 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Calandra1">[1]</xref>
###xml 373 376 373 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Leng1">[2]</xref>
###xml 988 991 988 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Chesney1">[3]</xref>
###xml 993 996 993 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Nishihira1">[4]</xref>
###xml 1056 1059 1056 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Karin1">[5]</xref>
###xml 1427 1430 1427 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Hardman1">[6]</xref>
###xml 1432 1435 1432 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Bucala1">[7]</xref>
Macrophage migration inhibitory factor (MIF) was originally described as a T cell-derived lymphokine but is now recognized as a pluripotent cytokine involved in multiple functions within and beyond the immune system [1]. In addition to its original ability to inhibit migration of macrophages, MIF exhibits a broad range of immunostimulatory and proinflammatory activities [2]. MIF is also produced by a variety of mesenchymal, parenchymal, and epithelial cell types, indicating its potential beyond the immune system. A number of studies have shown that MIF participates in the regulation of cell proliferation and differentiation and that it plays a role in the progress of septic shock, chronic inflammation, tissue damage, and autoimmune disease. Increased MIF mRNA expression has been reported in metastatic prostate cancer and ductal breast carcinoma. Following these findings, it became evident that MIF is involved in the development of lymphoma and tumor-associated angiogenesis [3], [4]. Inflammation is a critical component of tumor progression [5]. Many cancers arise from sites of infection, chronic irritation or inflammation. It is now becoming clear that the tumor microenvironment, which is strongly influenced by inflammatory cells, plays a major role in the neoplastic process, fostering proliferation, survival and migration of cancer cells. MIF represents an important link between inflammation and cancer [6], [7].
###end p 9
###begin p 10
###xml 528 531 528 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 617 620 617 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EPO</italic>
###xml 656 659 656 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Wang1">[8]</xref>
###xml 873 876 867 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Wang1">[8]</xref>
###xml 878 881 872 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Wang2">[9]</xref>
###xml 611 616 <span type="species:ncbi:9606">human</span>
In response to hypoxia, dramatic changes in gene expression occur leading to increased synthesis of proteins such as erythropoietin (EPO), glucose transporters (GLUT), glycolytic enzymes, vascular endothelial growth factor (VEGF), and matrix metalloproteinases, which mediate cellular and tissue adaptation. The changes in gene expression are controlled by the transcriptional activator hypoxia-inducible factor 1 (HIF-1). HIF-1 was identified and purified as a nuclear factor that was induced in hypoxic cells and bound to the cis-acting hypoxia response element (HRE) located in the 3'-flanking region of the human EPO gene, which encodes erythropoietin [8]. HIF-1 is a heterodimeric protein that is composed of HIF-1alpha and HIF-1(R) subunits. Both HIF-1 subunits are members of the basic helix-loop-helix-containing PER-ARNT-SIM-domain family of transcription factors [8], [9].
###end p 10
###begin p 11
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Schofield1">[10]</xref>
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Hirota1">[11]</xref>
###xml 246 247 238 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 504 508 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Maxwell1">[12]</xref>
###xml 631 632 615 616 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 692 696 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Epstein1">[13]</xref>
###xml 950 954 922 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Lando1">[14]</xref>
###xml 1005 1006 977 978 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1045 1049 1013 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Epstein1">[13]</xref>
###xml 1051 1055 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Lando1">[14]</xref>
###xml 1250 1254 1211 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Semenza1">[15]</xref>
###xml 1624 1628 1577 1581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Semenza2">[16]</xref>
###xml 1630 1634 1583 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Semenza3">[17]</xref>
###xml 1160 1165 <span type="species:ncbi:9606">human</span>
The regulation of cellular HIF-1 activity occurs at multiple levels [10], [11]. The mechanisms regulating HIF-1alpha protein levels and transcriptional activity have been extensively analyzed. Two proline residues of HIF-1alpha are subjected to O2-dependent hydroxylation, which is required for binding of the von Hippel-Lindau tumor-suppressor protein (VHL), which is the recognition component of a ubiquitin-protein ligase that targets HIF-1alpha for rapid proteasomal degradation in non-hypoxic cells [12]. Under hypoxic conditions, the hydroxylation of proline-402 and proline-564 of HIF-1alpha is inhibited due to substrate (O2) limitation, resulting in HIF-1alpha protein stabilization [13]. The transcriptional activity of HIF-1alpha is also negatively regulated under normoxic conditions by hydroxylation of asparagine-803, which prevents interaction of HIF-1alpha with the coactivators p300 and CBP, thus blocking transcriptional activation [14]. The prolyl and asparaginyl hydroxylases utilize O2 and alpha-ketoglutarate as substrates [13], [14]. In contrast, HIF-1beta is constitutively expressed in most cell types. Immunohistochemical analysis of human tumor biopsies has revealed overexpression of HIF-1alpha in various types of cancer [15]. High HIF-1alpha protein expression in tumors reflects stabilization of HIF-1alpha protein due to the frequent presence of intratumoral hypoxia as well as increased synthesis of the protein caused by genetic alterations involving oncogenes (such as HER2/neu) and tumor suppressor genes (such as p53, PTEN, and VHL) and autocrine growth factor signaling in cancer cells [16], [17]. HIF-1 activity is also induced by the stimulation of receptor tyrosine kinases or G protein-coupled receptors in cancer cells. HER2/neu activation increases the rate of HIF-1alpha protein synthesis via phosphatidylinositol 3-kinase (PI3K) and the downstream serine-threonine kinases AKT (protein kinase B) and mammalian target of rapamycin (mTOR). IGF-1-induced HIF-1alpha synthesis is dependent upon both the PI3K and MAP Kinase (MAPK) pathways.
###end p 11
###begin p 12
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Cramer1">[18]</xref>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Koong1">[19]</xref>
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Baugh1">[20]</xref>
###xml 253 258 <span type="species:ncbi:9606">human</span>
Both MIF and HIF-1 play critical roles in cancer and inflammation [18]. Moreover, MIF has been identified as a hypoxia-induced gene in cancer cells [19], [20]. Based on these findings we investigated the functional relationship between MIF and HIF-1 in human cancer cells. In this study, we demonstrate that intracellular overexpression or extracellular administration of MIF enhances activation of HIF-1 under hypoxic conditions and that the regulation is not dependent on redox activity of MIF but on wild-type p53.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
MIF induces HIF-1alpha protein expression under hypoxic conditions in MCF-7 cells
###end title 14
###begin p 15
###xml 354 361 354 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g001">Fig. 1A</xref>
###xml 409 410 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 591 598 580 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g001">Fig. 1A</xref>
###xml 700 701 685 686 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 862 863 844 845 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 876 883 858 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g001">Fig. 1A</xref>
###xml 973 980 951 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g001">Fig. 1B</xref>
###xml 108 113 <span type="species:ncbi:9606">human</span>
To investigate the impact of MIF on HIF-1 activity, the effect of intracellular transient overexpression of human MIF on HIF-1 protein expression was investigated. MCF-7 cells were transiently transfected with the expression vector pCMV-3xFLAG-hMIF or its empty vector pCMV-3xFLAG for 8 h. pCMV-3xFLAG-MIF significantly increased MIF protein expression (Fig. 1A, left panel). Cells were exposed to 20% or 1% O2 conditions for 4 h and then harvested for Western blotting analysis using anti-HIF-1alpha and HIF-1beta antibodies. HIF-1alpha protein expression was induced by hypoxic treatment (Fig. 1A, right panel, lane 3) and furthermore increased by MIF (lane 4). Expression of HIF-1alpha under 20% O2 conditions was not significantly affected by MIF overexpression. HIF-1beta protein expression was not affected by transient MIF overexpression under 1% or 20% O2 conditions (Fig. 1A, right panel). The effect of MIF overexpression on HIF-1alpha levels was dose-dependent (Fig. 1B).
###end p 15
###begin title 16
Effect of MIF on HIF-1 protein expression in MCF-7 cells.
###end title 16
###begin p 17
###xml 637 638 625 626 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1006 1007 981 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1030 1031 1005 1006 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 64 67 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 505 510 <span type="species:ncbi:9606">human</span>
(A and B) MCF-7 cells were transfected with 2 microg of p3xFLAG-CMV-10 plasmid (EV) or pFLAG-MIF plasmids (A and B lane 4; 2 microg, B lane 3; 0.5 microg). (C) MCF-7 cells were transfected by the plasmids for expression of FLAG tag (EV) and FLAG-tagged MIF and selected by puromycin resistance. Two clones of MCF-7 cells stably expressing FLAG tag (EV) and FLAG-tagged MIF (MIF#1 and MIF#2 cells) were established. (D) MCF-7 cells were treated with the indicated doses of bacterially produced recombinant human (rh)MIF. (E) MCF-7 cells were treated with rhMIF. Cells were exposed to 20% (A, B, C, and D), 5% (C), or 1% (A, B, C, and D) O2 conditions or treated with 100 microM DFX (E) for 4 h. Cell were harvested for immunoblot assay for MIF (A and C), HIF-1alpha and HIF-1beta protein (A, B, C, D, and E). Representative immunoblots are shown. Intensity of respective bands were analyzed densitometrically and fold induction to respective controls (lane1) are plotted accordingly as mean+/-S.D. (n = 3) *p<0.05 compared to 20% O2 conditions without MIF (lane 1) (ANOVA).
###end p 17
###begin p 18
###xml 130 137 130 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g001">Fig. 1C</xref>
###xml 283 284 279 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 286 293 282 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g001">Fig. 1C</xref>
###xml 356 357 348 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
We also investigated the effect of MIF using MCF-7 cells that stably expressed MIF. In two independent MIF-overexpressing clones (Fig. 1C, left panel), HIF-1alpha protein expression was induced more than control cells (lanes 2 and 3) under 5% (lanes 5 and 8) and 1% (lanes 6 and 9) O2 (Fig. 1C, right panel). HIF-1alpha expression was unchanged under 20% O2 regardless of the MIF expression level. HIF-1beta protein expression was not affected by MIF (data not shown).
###end p 18
###begin p 19
###xml 280 287 273 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g001">Fig. 1D</xref>
###xml 101 106 <span type="species:ncbi:9606">human</span>
Because MIF is a cellular factor released from cells, we next investigated the impact of recombinant human MIF protein (rhMIF) on MCF-7 cells. rhMIF increased HIF-1alpha expression in a dose-dependent manner under hypoxic conditions whereas HIF-1beta expression was not affected (Fig. 1D). rhMIF treatment also augmented HIF-1alpha protein levels in cells treated with iron chelator DFX which inhibits HIF-1alpha-hydroxylase activity.
###end p 19
###begin title 20
MIF induces HIF-1-dependent gene expression in MCF-7 cells
###end title 20
###begin p 21
###xml 177 178 177 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 201 208 201 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g002">Fig. 2A</xref>
###xml 272 273 272 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 514 521 510 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g002">Fig. 2A</xref>
We investigated whether MIF affected gene expression downstream of HIF-1 by RT-PCR analysis. MIF was transiently overexpressed in MCF-7 cells, which were exposed to 20% and 1% O2 for 18 h. As shown in Fig. 2A, VEGF and GLUT1 mRNA expression was induced by exposure to 1% O2 (1.73 and 1.77 fold, respectively). The induction of VEGF and GLUT1 mRNA was enhanced in hypoxic MIF-overexpressing MCF-7 cells (2.65 and 2.15 fold, respectively). Expression of HIF-1alpha mRNA was not affected by hypoxic or MIF treatment (Fig. 2A).
###end p 21
###begin title 22
Effect of MIF on HIF-1-dependent gene expressions.
###end title 22
###begin p 23
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 301 308 297 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 452 463 448 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B, C, and E</italic>
###xml 468 472 464 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 507 508 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1051 1052 1035 1036 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1168 1169 1150 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 287 291 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 783 787 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
(A) MCF-7 cells were transfected with the indicated plasmids and exposed to 20% or 1% O2 for 12 h. Then total RNA was isolated. Expression of VEGF, GLUT1, HIF-1alpha, and 18S rRNA was analyzed by RT-PCR using specific primer pairs. (B, C, D, and E) MCF-7 cells were transfected with pRL-SV40 encoding Renilla luciferase, FLAG-tagged MIF expression vector (B, C, and E), and one of the following plasmids encoding firefly luciferase: HRE reporter p2.1 (B, C, and E) or VEGF promoter reporter pVEGF-KpnI-Luc (D). (F) Constructs encoding the GAL4 DNA-binding domain (amino acids 1-147) fused to the indicated amino acids of HIF-1alpha were analyzed for their ability to transactivate reporter gene GAL4E1bLuc containing five GAL4-binding sites. MCF-7 cells were co-transfected with pRL-SV40 (50 ng), GAL4E1bLuc (100 ng), GAL4-HIF-1alpha fusion protein expression plasmids (100 ng), and FLAG-tagged MIF expression vector or empty vector (EV) (200 ng). Cells were treated with 100 microM of DFX or the indicated dose of rhMIF (F) and exposed to 20% or 1% O2 conditions for 18 h and then harvested. Results shown represent mean+/-S.D. of three independent transfections. *; p<0.05 compared to respective controls without MIF treatment (ANOVA).
###end p 23
###begin p 24
###xml 452 459 452 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g002">Fig. 2B</xref>
###xml 613 620 613 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g002">Fig. 2C</xref>
###xml 727 731 727 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 827 834 827 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g002">Fig. 2D</xref>
###xml 922 929 922 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g002">Fig. 2E</xref>
###xml 721 726 <span type="species:ncbi:9606">human</span>
To determine whether the increase in VEGF and GLUT1 mRNA levels reflected an increase in HIF-1 transcriptional activity, MCF-7 cells were transfected with empty vector or FLAG-tagged MIF expression vector and the HRE-containing reporter plasmid p2.1. Overexpression of MIF significantly increased HRE-dependent gene expression significantly even under normoxic conditions and under hypoxic conditions in a MIF expression plasmid-dose dependent manner (Fig. 2B). Exposure of cells to bacterially produced rhMIF in the culture media also induced HRE-dependent gene expression under normoxic and hypoxic conditions (Fig. 2C). MIF also induced dose-dependent transcription of a luciferase reporter gene containing the intact human VEGF gene promoter encompassing nucleotides -2274 to +379 relative to the transcription start site (Fig. 2D). Overexpression of MIF also potentiated HRE-dependent gene expression induced by DFX (Fig. 2E).
###end p 24
###begin p 25
###xml 583 587 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Jiang1">[21]</xref>
###xml 696 703 676 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g002">Fig. 2F</xref>
###xml 728 729 708 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Next, we investigated the impact of MIF on HIF-1alpha transcriptional activity. There are two independent transactivation domains (TADs) present in HIF-1alpha, which are designated as the amino-terminal (amino acids 531-575) and carboxyl-terminal (amino acids 786-826) TADs. A fusion protein consisting of the GAL4 DNA-binding domain fused to HIF-1alpha residues 531-826, which contains both TADs, is expressed at similar levels under hypoxic and non-hypoxic conditions and thus can be used to examine the transcriptional activity of HIF-1alpha independent of its protein expression [21]. rhMIF treatment increased transactivation mediated by GAL4-HIF-1alpha(531-826) in a dose-dependent manner (Fig. 2F) under both 20% and 1% O2 conditions. Thus, MIF not only increased HIF-1alpha protein levels but also the transcriptional activity of HIF-1alpha.
###end p 25
###begin title 26
MIF and TRX differentially regulate HIF-1 activity in MCF-7 cells
###end title 26
###begin p 27
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Kleemann1">[22]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Thiele1">[24]</xref>
###xml 383 390 379 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g003">Fig. 3A</xref>
###xml 437 438 433 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 590 597 582 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g003">Fig. 3A</xref>
###xml 725 732 714 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g003">Fig. 3A</xref>
Because MIF is also an enzyme that exhibits oxidoreductase activity based on cysteine thiol-mediated mechanism [22]-[24], we next explored a possibility that the effect of MIF on HIF-1alpha is dependent on its redox activity. Wild-type MIF (MIF-wt) or its redox mutant MIF-C57/60S expression plasmid, which lacks oxidoreductase activity, was introduced transiently into MCF-7 cells (Fig. 3A, left panel) Cells were exposed to 20% or 1% O2 and cell lysates were subjected to immunoblot assays. The redox mutant MIF-C57/60S also increased HIF-1alpha protein expression in either transiently (Fig. 3A, right panel) or stably MIF-expressing cells (data not shown). HIF-1beta expression was not affected by MIF-wt or MIF-C57/60S (Fig. 3A, right panel).
###end p 27
###begin title 28
Effect of mutation of MIF on HIF-1 activity.
###end title 28
###begin p 29
###xml 526 527 513 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 550 551 537 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 665 672 652 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 771 772 758 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 950 957 937 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1111 1112 1096 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 64 67 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 139 142 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 651 655 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
(A and B) MCF-7 cells were transfected with 2 microg of p3xFLAG-CMV-10 plasmid, pFLAG-MIF-wt, or pFLAG-MIF-C57/60S plasmids (A) or p3xFLAG-CMV-10 plasmid, pFLAG-TRX-wt, or pFLAG-TRX-C32/35S plasmids (B). Cell were harvested for immunoblot assay for MIF (left panel), HIF-1alpha and HIF-1beta protein (right panel). Experiments are repeated for three times. Representative immunoblots are shown. Intensity of respective bands were analyzed densitometrically and fold induction to lane 1 are plotted accordingly as mean+/-S.D. *p<0.05 compared to 20% O2 conditions without MIF treatment. (C) MCF-7 cells were transfected with p2.1 reporter plasmid, pRL-SV40 encoding Renilla luciferase and FLAG-tagged TRX-wt or -C32/35S expression vector. Cells were exposed to 20% or 1% O2 conditions for 18 h and then harvested. The luciferase activity of the lysates was determined using the Dual-Luciferase Reporter Assay System (Promega). The ratio of firefly to Renilla luciferase activity was determined. A normalized mean count+/-S.D. of three independent transfections is shown as relative luciferase activity (RLA). *; p<0.05 compared to respective control (ANOVA).
###end p 29
###begin p 30
###xml 286 293 286 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g003">Fig. 3B</xref>
###xml 440 447 436 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g003">Fig. 3B</xref>
###xml 619 626 608 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g003">Fig. 3B</xref>
###xml 766 773 755 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g003">Fig. 3C</xref>
###xml 813 817 802 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Ema1">[25]</xref>
We next examined the effect of TRX, which also has thiol-reducing activity and shares a similar catalytic center with MIF. The wild-type TRX (TRX-wt) expression plasmid pCMV-3xFLAG-TRX-wt or its redox inactive mutant pCMV-3xFLAG-TRX-C32/35S was introduced transiently into MCF-7 cells (Fig. 3B, left panel). Expression of wild-type or mutant- TRX did not affect the baseline expression or hypoxia- or DFX-induced HIF-1alpha protein levels (Fig. 3B, right panel). In addition, addition of rhTRX to the culture media did not affect expression of HIF-1alpha (data not shown). HIF-1beta expression was not affected by TRX (Fig. 3B, right panel). In contrast, expression of TRX-wt augmented, whereas TRX-C32/35S suppressed, hypoxia-induced HRE-dependent gene expression (Fig. 3C), as reported previously in HeLa cells [25].
###end p 30
###begin p 31
###xml 242 255 238 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g004">Fig. 4A and B</xref>
###xml 281 282 277 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 422 423 414 415 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 513 526 501 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g004">Fig. 4A and B</xref>
###xml 608 609 596 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 726 727 707 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 740 747 721 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g004">Fig. 4C</xref>
To investigate the effect of loss of function of MIF or TRX on HIF-1alpha protein levels, siRNA for MIF or TRX was introduced into MCF-7 cells. Protein expression of MIF or TRX was significantly suppressed by introduction of specific siRNAs (Fig. 4A and B, left panels). Under 1% O2 conditions, hypoxia-induced HIF-1alpha protein expression was inhibited by suppression of MIF but not that of TRX. In contrast, under 20% O2 conditions, expression of HIF-1alpha was not affected by knockdown of either MIF or TRX (Fig. 4A and B, right panel). Finally, MCF-7 cells were treated with antioxidants. Vitamin E or N-acetyl cysteine treatment did not affect HIF-1alpha or HIF-1beta protein expression in MCF-7 cells under 20% or 1% O2 conditions (Fig. 4C).
###end p 31
###begin title 32
Effect of MIF-gene silencing on HIF-1 activity.
###end title 32
###begin p 33
###xml 170 171 170 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 507 508 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 531 532 522 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 680 681 663 664 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 873 874 849 850 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1056 1063 1028 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1154 1155 1126 1127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1271 1272 1241 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1042 1046 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
(A, B, and D) MCF-7 cells were transfected with siRNA against MIF, TRX, CD74, or green fluorescence protein (GFP) as a negative control. Cells were exposed to 20% or 1% O2 conditions and were harvested for immunoblot assay for MIF or TRX (left panels) or HIF-1alpha and HIF-1beta protein expression (right panels). Representative immunoblots are shown. Intensity of respective bands were analyzed densitometrically and fold induction to lane 1 are plotted accordingly as mean+/-S.D. (n = 3) (A, B, and C). *p<0.05 compared to 20% O2 conditions without treatment (ANOVA). (C) MCF-7 cells were pre-treated with 10 microM alpha-tocopherol or 10 mM NAC and then exposed to 20% or 1% O2 conditions for 4 h. Cells were harvested for immunoblot assay for HIF-1alpha and HIF-1beta protein. (D) siRNAs for GFP or CD74 were introduced into MCF-7 cells. The cells were exposed to 1% O2 with or without rhMIF treatment. Cells were harvested for immunoblot assay for MIF HIF-1alpha protein. (E) MCF-7 cells were transfected with HRE reporter p2.1 and pRL-SV40 encoding Renilla luciferase. Cells were treated with the indicated dose of rhMIF and exposed to 20% or 1% O2 conditions for 18 h and then harvested. Results shown represent mean+/-S.D. of three independent transfections. *; p<0.05 compared to respective controls (ANOVA).
###end p 33
###begin title 34
The effects of MIF is dependent on CD74 and ERK activity
###end title 34
###begin p 35
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Leng2">[26]</xref>
###xml 195 196 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 330 331 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 344 351 340 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g004">Fig. 4D</xref>
We examined effect of interfering with the high-affinity binding protein for MIF CD74 mRNA expression [26]. siRNAs for GFP or CD74 were introduced into MCF-7 cells. The cells were exposed to 1% O2 with or without rhMIF treatment. Knockdown of CD74 expression abrogated effect of MIF over HIF-1alpha protein accumulation under 1% O2 conditions (Fig. 4D).
###end p 35
###begin p 36
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Amin1">[27]</xref>
###xml 266 267 266 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 280 287 280 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g004">Fig. 4E</xref>
Because it was reported that MIF induced angiogenesis in a MAPK-dependent manner [27], we examined involvement of MAPK in MIF-elicited HIF-1 activation. Treatment with the MEK inhibitor PD98059 or U0126 suppressed MIF-induced HRE-dependent gene expression under 1% O2 conditions (Fig. 4E).
###end p 36
###begin title 37
The effect of MIF is not dependent on Jab1/CSN5 in MCF-7 cells
###end title 37
###begin p 38
###xml 285 289 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Bae1">[28]</xref>
###xml 373 377 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Kleemann3">[29]</xref>
###xml 541 548 525 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g005">Fig. 5A</xref>
###xml 585 592 569 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g005">Fig. 5B</xref>
###xml 633 634 617 618 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Bae et al. reported that Jab1 (coactivator of c-Jun, also known as the CSN5 subunit of the COP9 signalosome) interfered with the binding of HIF-1alpha to the p53 tumor suppressor protein and thereby increased HIF-1alpha protein levels by enhancing HIF-1alpha stability in HEK293 cells [28]. Because MIF interacts with Jab1 and negatively regulates Jab1-controlled pathways [29], we investigated whether MIF-induced HIF-1 activation is dependent on Jab1. However, we failed to detect any effect of Jab1/CSN5 on HIF-1alpha protein expression (Fig. 5A) and HRE-dependent gene expression (Fig. 5B) in MCF-7 cells under either 20% or 1% O2 conditions.
###end p 38
###begin title 39
Involvement of Jab1 in MIF-induced HIF-1 activation.
###end title 39
###begin p 40
###xml 106 107 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 414 415 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 438 439 421 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 465 474 448 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Student t</italic>
###xml 561 568 544 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 670 671 645 646 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 849 856 824 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 547 551 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
(A) MCF-7 cells were transfected with pSRalpha-HA-1 or pSRalpha-HA-Jab1. Cells were exposed to 20% or 1% O2 conditions and were harvested for immunoblot assay for Jab1 (left panels) or HIF-1alpha and HIF-1beta protein expression (right panels). Representative immunoblots are shown. Intensity of respective bands were analyzed densitometrically and fold induction to lane 1 are plotted accordingly as mean+/-S.D. *p<0.05 compared to 20% O2 conditions without Jab1 (Student t-test). (B) MCF-7 cells were transfected with p2.1 reporter plasmid, pRL-SV40 encoding Renilla luciferase and pSRalpha-HA-1 or pSRalpha-HA-Jab1 expression vector. Cells were exposed to 20% or 1% O2 conditions for 18 h and then harvested. The luciferase activity of the lysates was determined using the Dual-Luciferase Reporter Assay System (Promega). The ratio of firefly to Renilla luciferase activity was determined. A normalized mean count+/-S.D. of three independent transfections is shown as relative luciferase activity (RLA).
###end p 40
###begin title 41
The effect of MIF is dependent on p53
###end title 41
###begin p 42
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Bae1">[28]</xref>
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Mitchell1">[30]</xref>
###xml 325 332 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g006">Fig. 6A</xref>
###xml 480 481 472 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 520 527 512 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g006">Fig. 6B</xref>
###xml 635 642 627 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g006">Fig. 6C</xref>
###xml 752 756 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Brummelkamp1">[31]</xref>
###xml 808 815 800 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g006">Fig. 6D</xref>
###xml 1143 1150 1131 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g006">Fig. 6E</xref>
MIF was identified as a binding protein and a functional suppressor of p53 [28], [30]. We next explored a possibility that p53 is involved in MIF-induced HIF-1 activation. The effect of rhMIF on HIF-1alpha protein expression in MDA-MB-231 cells, which express mutant p53, and p53-null osteosarcoma Saos-2 cells was examined (Fig. 6A). In contrast to results with MCF-7 cells harboring wild-type p53, rhMIF treatment did not increase HIF-1alpha protein expression under 20% or 1% O2 in either MDA-MB-231 or Saos-2 cells (Fig. 6B). Moreover, rhMIF treatment did not enhance hypoxia-induced HRE-dependent gene expression in Saos-2 cells (Fig. 6C). In accord with this result, MCF-7 cells transfected with the vector encoding short-hairpin RNA against p53 [31] did not respond to rhMIF under hypoxic conditions (Fig. 6D), although basal HIF-1 activity was unregulated by knockdown of p53. To investigate involvement of wild-type p53 in regulation of HIF-1alpha protein, binding between MIF and p53 in MCF-7 and MDA-MB-231 cells was examined. The amount of captured p53 was less in MDA-MB-231 cells than MCF-7 cells, which expresses wild-type p53 (Fig. 6E).
###end p 42
###begin title 43
Involvement of p53 in MIF-induced HIF-1 activation.
###end title 43
###begin p 44
###xml 71 72 71 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 459 460 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 705 706 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 841 842 832 833 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 301 305 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 415 419 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
(A and B) MDA-MB-231 cells and Saos-2 cells were exposed to 20% or 1% O2 conditions with or without rhMIF treatment for 4 h and then harvested for immunoblot assay for p53 (A) and HIF-1alpha and HIF-1beta protein (B). (C and D) MCF-7 cells and Saos-2 cells were transfected with p2.1 reporter and pRL-SV40 (C). MCF-7 cells transfected with pSUPER (EV) or pSUPER-p53(p53) were transfected with p2.1 reporter and pRL-SV40 (D). Cells were exposed to 20% and 1% O2 conditions with or without rhMIF treatment and then harvested for luciferase assay. Fold induction of relative luciferase activity was calculated. A normalized mean value+/-S.D. of three independent transfections is shown as fold induction. *; p<0.05 compared to respective control (ANOVA). (E) MCF-7 and MDA-MB-231 cells transfected with pFLAG-MIF-wt plasmid were exposed to 1% O2 and then cells were harvested. 500 microg of lysates were incubated with anti-FLAG affinity agarose beads and captured protein was eluted and analyzed by Western blot with anti-p53 antibody. 50 microg of lysate were analyzed by Western blot with anti-p53 antibody.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
In this study, we demonstrate that intracellular overexpression or extracellular administration of MIF increased HIF-1alpha protein expression and HIF-1-dependent gene expressions in MCF-7 breast cancer cells. Knockdown of MIF or CD74 expression by siRNA suppressed hypoxia-induced HIF-1alpha activation. In addition, we demonstrated that the effect of MIF on HIF-1 is observed only in the presence of wild-type not but mutant p53.
###end p 46
###begin p 47
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Kleemann3">[29]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Hudson1">[32]</xref>
We adopted two protocols of MIF treatment. One is intracellular overexpression of MIF, and extracellular administration of bacterially produced rhMIF. Both the treatments enhanced hypoxia-induced HIF-1 activation. It is proposed that cells take up extracellular MIF is taken by endocytosis in membrane-bound vesicles, which interact with intracellular signaling molecules including Jab1/CSN5 [29] and p53 [32].
###end p 47
###begin p 48
###xml 138 142 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Bae1">[28]</xref>
###xml 144 148 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Kleemann3">[29]</xref>
###xml 150 154 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Bemis1">[33]</xref>
###xml 284 288 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Bae1">[28]</xref>
###xml 290 294 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Winner1">[34]</xref>
###xml 435 436 423 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 227 231 <span type="species:ncbi:108852">paca</span>
MIF interacts with the intracellular signaling intermediate Jab1/CSN5, which was reported to regulate the stability of HIF-1alpha protein [28], [29], [33]. Overexpression of Jab1 stabilizes HIF-1alpha protein in HEK293 and MIA-paca-2 cells and activates HIF-1-dependent transcription [28], [34]. But in MCF-7 cells, forced expression of Jab1 did not increase HIF-1alpha protein or HRE-dependent gene expression under either 20% or 1% O2. These results indicate that Jab1/CSN5 does not critically contribute to MIF-induced HIF-1 activation in MCF-7 cells. The molecular mechanism underlying the difference between cell lines remains to be established.
###end p 48
###begin p 49
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Kleemann1">[22]</xref>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Thiele1">[24]</xref>
###xml 128 134 128 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g004">Fig. 4</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Thiele1">[24]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Welsh1">[35]</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Welsh2">[36]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Ema1">[25]</xref>
###xml 487 488 483 484 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 496 497 492 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 520 527 516 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g003">Fig. 3C</xref>
###xml 532 534 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g004">4B</xref>
###xml 621 628 613 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g004">Fig. 4C</xref>
Several reports demonstrated that MIF is an oxidoreductase with insulin disulfide bond reducing activity [22]-[24]. As shown in Fig. 4, the redox mutant MIF-C57S/C60S can activate HIF-1. TRX is also an oxidoreductase that is involved in intracellular signal transduction [24]. In contrast to previous reports using MCF-7 cells [35], [36], but in accordance with our report using HeLa cells [25], neither overexpression nor knockdown of TRX affected HIF-1alpha protein expression at 20% O2 or 1% O2 in the present study (Fig. 3C and 4B). Moreover, treatment with antioxidants did not affect HIF-1alpha protein expression (Fig. 4C). Together, we conclude that MIF enhances HIF-1 activity in a redox activity-independent manner.
###end p 49
###begin p 50
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Leng2">[26]</xref>
###xml 269 276 265 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g004">Fig. 4D</xref>
###xml 503 504 499 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 504 508 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Mitchell2">[37]</xref>
###xml 510 514 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Lue1">[38]</xref>
###xml 653 660 645 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g004">Fig. 4E</xref>
###xml 799 805 791 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g007">Fig. 7</xref>
The type II transmembrane protein CD74 was identified as a high-affinity binding protein for MIF [26]. In this study, we indicated that knockdown of CD74 expression by siRNA made MCF-7 cells to be insensitive to MIF treatment in expression of HIF-1alpha under hypoxia (Fig. 4D). MIF binds to the extracellular domain of CD74, and CD74 is required for MIF-induced activation of the extracellular signal-regulated kinase-1/2 MAP kinase cascade, cell proliferation, and release of arachidonates such as PGE2[37], [38]. We also showed that MIF-induced HIF-1alpha transcriptional activation in MCF-7 cells was blocked by the MEK inhibitors PD98059 or U0126 (Fig. 4E). The evidence indicates that CD74-dependent signaling pathway contributes to extracellularly administrated MIF-induced HIF-1 activation (Fig. 7).
###end p 50
###begin title 51
Involvement of MIF in HIF-1 regulation in MCF-7 cells.
###end title 51
###begin p 52
HIF-1alpha protein stabilization and transactivation activity induced by MIF is dependent on p53- and MAPK-dependent signaling pathway.
###end p 52
###begin p 53
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Mitchell1">[30]</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-FingerleRowson1">[39]</xref>
###xml 160 167 156 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 239 243 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Ravi1">[40]</xref>
###xml 279 285 271 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g006">Fig. 6</xref>
###xml 456 462 440 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002215-g007">Fig. 7</xref>
MIF is a potent cytokine that overcomes p53 function by suppressing its transcriptional activity [30], [39]. It was reported that p53 interacts with HIF-1alpha in vivo and that p53 promotes the ubiquitin-mediated degradation of HIF-1alpha [40]. The experimental results shown as Fig. 6 indicates that effect of MIF on HIF-1 is p53-dependent and suggests that MIF stabilizes HIF-1alpha protein under hypoxic conditions by sequestrating p53 from HIF-1alpha (Fig. 7).
###end p 53
###begin p 54
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Shimizu1">[41]</xref>
In addition to MIF's potent effects on the immune system, MIF is linked to fundamental processes conferring cell proliferation, cell survival, angiogenesis, and tumor invasiveness. A line of studies report the increased expression of MIF in solid tumors. Several studies also indicate that MIF expression closely correlates with tumor aggressiveness and metastatic potential, suggesting as important contribution to cancer malignancy by MIF [41]. The link of MIF to HIF-1alpha protein stabilization and transactivation activity provides molecular mechanism for MIF-dependent promotion of tumorigenesis.
###end p 54
###begin title 55
Materials and Methods
###end title 55
###begin title 56
Cell culture and reagents
###end title 56
###begin p 57
###xml 247 248 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 533 537 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Sasada1">[42]</xref>
###xml 539 543 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Hirota2">[43]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 387 392 <span type="species:ncbi:9606">human</span>
###xml 454 459 <span type="species:ncbi:9606">human</span>
Human breast carcinoma MCF-7 (wild-type p53), MDA-MB-231 (mutant p53), and osteosarcoma Saos-2 (p53-null) cell lines were grown in Dulbecco's modified essential medium supplemented with 10% FBS, 100 units/ml penicillin, and 100 g/ml streptomycin. N-acetyl-cysteine (NAC), the iron chelator desferrioxamine (DFX), and alpha-tocopherol were from Sigma-Aldrich (St. Louis, MO). Recombinant human (rh) MIF was from R&D systems (Minneapolis, MN). Recombinant human thioredoxin (TRX) was prepared following a protocol described previously [42], [43].
###end p 57
###begin title 58
Plasmids
###end title 58
###begin p 59
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Sawano1">[44]</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Hirota2">[43]</xref>
###xml 815 819 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Moriguchi1">[45]</xref>
###xml 949 953 941 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Brummelkamp1">[31]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 155 160 <span type="species:ncbi:9606">human</span>
###xml 315 318 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Human MIF or Jun activation domain-binding protein 1(Jab1) cDNA was cloned by RT-PCR from a HeLa cell cDNA library, using specific primers to based on the human MIF or Jab1 sequence, respectively. For expression plasmids with N-terminal 3xFLAG-tagged MIF and TRX, PCR-amplified fragments were inserted into p3xFLAG-CMV-10 plasmid (Sigma-Aldrich). Mutagenesis of MIF (C57/60S) was performed using a protocol on pCMV-3xFLAG-MIF [44]. C32/35S-TRX mutant was described previously [43]. To establish stable transfectants, 3xFLAG-tagged expression cassettes of MIF and TRX were amplified by PCR and transferred to the expression vector pQCXIP (Clonthech, Palo Alto, CA). For the influenza hemagglutin (HA) epitope-tagged Jab1 expression plasmid pSRalpha-HA-Jab1, PCR-amplified cDNA of Jab1 was inserted into pSRalpha-HA1 [45]. A vector encoding short-hairpin RNA against p53 (pSUPER-p53) was kindly provided by Dr. Agami, the Netherlands Cancer Institute [31].
###end p 59
###begin title 60
Hypoxic treatment
###end title 60
###begin p 61
###xml 131 132 131 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 138 139 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 145 146 145 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 181 185 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Oda1">[46]</xref>
###xml 187 191 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Kasuno1">[47]</xref>
Tissue culture dishes were transferred to a modular incubator chamber (Billups-Rothenberg, Del Mar, CA) which was flushed with 1% O2-5% CO2-94% N2, sealed, and placed at 37degreesC [46], [47].
###end p 61
###begin title 62
Immunoblot assays
###end title 62
###begin p 63
###xml 178 179 178 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 300 301 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 736 740 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Oda1">[46]</xref>
###xml 486 491 <span type="species:ncbi:10090">mouse</span>
###xml 633 638 <span type="species:ncbi:9940">sheep</span>
###xml 656 661 <span type="species:ncbi:10090">mouse</span>
###xml 856 862 <span type="species:ncbi:9986">rabbit</span>
###xml 1131 1135 <span type="species:ncbi:9925">goat</span>
###xml 1153 1159 <span type="species:ncbi:9986">rabbit</span>
Whole cell lysates were prepared using ice-cold lysis buffer [0.1% SDS, 1% NP40, 5 mM EDTA, 150 mM NaCl, 50 mM Tris-Cl (pH 8.0)] supplemented with7 2 mM dithiothreitol, 1 mM NaVO3, and Complete protease inhibitortrade mark (Roche Diagnostics, Basel, Switzerland). Samples were centrifuged at 10,000x g to pellet cell debris. For HIF-1alpha and HIF-1beta, 100-microg aliquots were fractionated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and subjected to immunoblot assay using mouse monoclonal antibodies against HIF-1alpha (BD Biosciences, San Jose, CA), or HIF-1beta (BD Biosciences) at 1:1000 dilution and HRP-conjugated sheep antibody against mouse IgG (GE Healthcare Bio-Science Corp., Piscataway, NJ.) at 1:2000 dilution [46]. For MIF, TRX, Jab1, and p53, 20-microg aliquots were analyzed by SDS-PAGE and subjected to immunoblot assay using rabbit polyclonal antibodies against MIF (FL-115, Santa Cruz Biotechnology, Inc., Santa Cruz, CA), TRX (FL-105, Santa Cruz Biotechnology, Inc), Jab1 (FL-334, Santa Cruz Biotechnology, Inc.), and p53 (DO-1, Santa Cruz Biotechnology, Inc) at 1:1000 dilution and HRP-conjugated goat antibody against rabbit IgG (GE Healthcare Bio-Science Corp.) at 1:2000 dilution. Chemiluminescent signal was developed using ECL reagent (GE Healthcare Bio-Science Corp.).
###end p 63
###begin title 64
Reverse Transcription (RT)-PCR
###end title 64
###begin p 65
###xml 45 49 45 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Oda1">[46]</xref>
###xml 51 55 51 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002215-Kasuno1">[47]</xref>
The RT-PCR protocol was described previously [46], [47]. After treatment, cells were harvested and RNA was isolated with TRIzoltrade mark (Invitrogen). 1 microg of total RNA was subjected to first strand cDNA synthesis using random hexamers (SuperScript II RT kit, Invitrogen). cDNAs were amplified with TaqGoldtrade mark polymerase (Roche Diagnostics) in a thermal cycler with the specific primers (sequences provided on request). For each primer pair, PCR was optimized for cycle number to obtain linearity between the amount of input RT product and output PCR product. Thermocycling conditions were 30 s at 94degreesC, 60 s at 57degreesC, and 30 s at 72degreesC for 28 (glucose transporter 1 [GLUT1]), 25 (VEGF and HIF-1alpha) and 22 (18S) cycles preceded by 10 min at 94degreesC. PCR products were fractionated by 1% SeaKem GTG Agarose gel electrophoresis, stained with ethidium bromide, and visualized with UV.
###end p 65
###begin title 66
Reporter Gene Assays
###end title 66
###begin p 67
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 705 723 701 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla reniformis</italic>
###xml 1240 1247 1227 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 189 193 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 638 642 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 669 673 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 705 723 <span type="species:ncbi:6136">Renilla reniformis</span>
Reporter assays were performed in MCF-7 cells. 5x104 cells were plated per well on the day before transfection. Plasmid p2.1 contains a 68-bp HRE from the ENO1 gene inserted upstream of an SV40 promoter in the luciferase reporter plasmid pGL2-Promoter (Promega, Madison, WI). Constructs encoding the GAL4 DNA-binding domain (amino acids 1-147) fused to the amino acids of HIF-1alpha (531-826) were analyzed for their ability to transactivate reporter gene GAL4E1bLuc, which contains 5 copies of a GAL4 binding site upstream of a TATA sequence and firefly luciferase coding sequences. The reporter gene plasmid and the control plasmid pRL-SV40 (Promega), which contains SV40 promoter sequences upstream of Renilla reniformis luciferase coding sequences, were pre-mixed and used. In each transfection, indicated dose of test plasmids, 200 ng of reporter gene plasmid, and 50 ng of the control were pre-mixed with Fugene 6trade mark transfection reagent (Roche Diagnostics). In each assay the total amount of DNA was held constant by addition of corresponding empty vectors. After treatment, the cells were harvested and the luciferase activity was determined using the Dual-Luciferase Reporter Assay System (Promega). The ratio of firefly to Renilla luciferase activity was determined. A normalized mean+/-S.D. based on three independent transfections is shown as relative luciferase activity (RLA).
###end p 67
###begin title 68
Gene silencing using short interfering RNA (siRNA)
###end title 68
###begin p 69
###xml 124 153 124 153 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCUGCACAGCAUCGGCAAdTdT-3&#8242;</named-content>
###xml 158 187 158 187 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-UUGCCGAUGCUGUGCAGGCdTdT-3&#8242;</named-content>
###xml 197 200 197 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MIF</sub>
###xml 205 234 205 234 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCAUCUGCGUGACAAUAAAdTdT-3&#8242;</named-content>
###xml 239 268 239 268 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-UUUAUUGUCACGCAGAUGGdTdT-3&#8242;</named-content>
###xml 278 281 278 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRX</sub>
###xml 367 372 <span type="species:ncbi:9606">human</span>
###xml 379 382 <span type="species:ncbi:9685">cat</span>
Two oligonucleotides consisting of ribonucleosides except for the presence of 2'-deoxyribonucleosides (dTdT) at the 3' end, 5'-GCCUGCACAGCAUCGGCAAdTdT-3' and 5'-UUGCCGAUGCUGUGCAGGCdTdT-3' for siRNAMIF and 5'-CCAUCUGCGUGACAAUAAAdTdT-3' and 5'-UUUAUUGUCACGCAGAUGGdTdT-3' for siRNATRX, were synthesized and annealed (Qiagen Inc., Valencia, CA.). siRNAs corresponding to human CD74 (cat. no. SI00063049) were from Qiagen Inc. MCF-7 cells were transfected by 100 nM siRNA using HiPerFecttrade mark Transfection Reagent (Qiagen Inc.) following a protocol provided by the manufacturer.
###end p 69
###begin title 70
Data analysis
###end title 70
###begin p 71
###xml 182 190 180 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 209 210 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
All the experiments were done at least three times (unless mentioned otherwise) and representative blots are shown. Data were expressed as mean+/-S.D. Significance tests (ANOVA with post-hoc test or Student's t-test) were performed using Prismtrade mark version 4 application.
###end p 71
###begin p 72
We thank Dr. Reuven Agami (The Netherlands Cancer Institute, Amsterdam) for providing plasmids.
###end p 72
###begin title 73
References
###end title 73
###begin article-title 74
Macrophage migration inhibitory factor: a regulator of innate immunity.
###end article-title 74
###begin article-title 75
Macrophage migration inhibitory factor.
###end article-title 75
###begin article-title 76
###xml 103 109 <span type="species:ncbi:10090">murine</span>
An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma.
###end article-title 76
###begin article-title 77
Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth.
###end article-title 77
###begin article-title 78
Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.
###end article-title 78
###begin article-title 79
Macrophage migration inhibitory factor: a central regulator of wound healing.
###end article-title 79
###begin article-title 80
Macrophage migration inhibitory factor: a probable link between inflammation and cancer.
###end article-title 80
###begin article-title 81
Purification and characterization of hypoxia-inducible factor 1.
###end article-title 81
###begin article-title 82
###xml 94 95 94 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
###end article-title 82
###begin article-title 83
Oxygen sensing by HIF hydroxylases.
###end article-title 83
###begin article-title 84
Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases.
###end article-title 84
###begin article-title 85
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
###end article-title 85
###begin article-title 86
###xml 0 10 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.
###end article-title 86
###begin article-title 87
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.
###end article-title 87
###begin article-title 88
Targeting HIF-1 for cancer therapy.
###end article-title 88
###begin article-title 89
HIF-1: using two hands to flip the angiogenic switch.
###end article-title 89
###begin article-title 90
HIF-1 and tumor progression: pathophysiology and therapeutics.
###end article-title 90
###begin article-title 91
HIF-1alpha is essential for myeloid cell-mediated inflammation.
###end article-title 91
###begin article-title 92
Candidate genes for the hypoxic tumor phenotype.
###end article-title 92
###begin article-title 93
Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1.
###end article-title 93
###begin article-title 94
Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension.
###end article-title 94
###begin article-title 95
Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase.
###end article-title 95
###begin article-title 96
Characterization of catalytic centre mutants of macrophage migration inhibitory factor (MIF) and comparison to Cys81Ser MIF.
###end article-title 96
###begin article-title 97
Link between macrophage migration inhibitory factor and cellular redox regulation.
###end article-title 97
###begin article-title 98
Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300.
###end article-title 98
###begin article-title 99
MIF signal transduction initiated by binding to CD74.
###end article-title 99
###begin article-title 100
Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase.
###end article-title 100
###begin article-title 101
Jab1 interacts directly with HIF-1alpha and regulates its stability.
###end article-title 101
###begin article-title 102
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.
###end article-title 102
###begin article-title 103
Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.
###end article-title 103
###begin article-title 104
A system for stable expression of short interfering RNAs in mammalian cells.
###end article-title 104
###begin article-title 105
A proinflammatory cytokine inhibits p53 tumor suppressor activity.
###end article-title 105
###begin article-title 106
Distinct aerobic and hypoxic mechanisms of HIF-alpha regulation by CSN5.
###end article-title 106
###begin article-title 107
Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization.
###end article-title 107
###begin article-title 108
The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
###end article-title 108
###begin article-title 109
The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation.
###end article-title 109
###begin article-title 110
Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action.
###end article-title 110
###begin article-title 111
Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
###end article-title 111
###begin article-title 112
The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting.
###end article-title 112
###begin article-title 113
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
###end article-title 113
###begin article-title 114
###xml 61 66 <span type="species:ncbi:9606">human</span>
High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis.
###end article-title 114
###begin article-title 115
###xml 94 99 <span type="species:ncbi:9606">human</span>
Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity.
###end article-title 115
###begin article-title 116
AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1.
###end article-title 116
###begin article-title 117
Directed evolution of green fluorescent protein by a new versatile PCR strategy for site-directed and semi-random mutagenesis.
###end article-title 117
###begin article-title 118
A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3.
###end article-title 118
###begin article-title 119
Activation of hypoxia-inducible factor 1 during macrophage differentiation.
###end article-title 119
###begin article-title 120
Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling.
###end article-title 120
###begin p 121
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 121
###begin p 122
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a grant-in-aids for scientific research from ministry of education, culture, sports, science and technology, JAPAN (to TA and KH).
###end p 122

